RO4929097
Catalog No. A10802
RO4929097是一种γ secretase抑制剂,无细胞试验中IC50为4 nM。抑制Aβ40和Notch的细胞加工,EC50分别为14 nM和5 nM。
- Hirosumi Tamura, .et al. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues, Oncol Rep, 2018, Aug; 40(2): 635-646 PMID: 29917168
Catalog Num | A10802 |
---|---|
M. Wt | 469.4 |
Formula | C22H20F5N3O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 847925-91-1 |
Synonyms | |
SMILES | CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3NC1=O |
RO4929097是一种γ secretase抑制剂,无细胞试验中IC50为4 nM。抑制Aβ40和Notch的细胞加工,EC50分别为14 nM和5 nM。
Targets
γ secretase (Cell-free assay) | γ secretase(ICN) (Cell-free assay) | Aβ40 (Cell-free assay) | ||
4 nM | 5 nM | 14 nM |
In vitro (25°C) | DMSO | 92 mg/mL (195.99 mM) | |
Water | Insoluble | ||
Ethanol | 16 mg/mL | ||
In vivo | 2% DMSO+30% PEG 300+5% Tween+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.3 mL | 106.52 mL | 213.04 mL |
0.5 mM | 4.26 mL | 21.3 mL | 42.61 mL |
1 mM | 2.13 mL | 10.65 mL | 21.3 mL |
5 mM | 0.43 mL | 2.13 mL | 4.26 mL |
*The above data is based on the productmolecular weight 469.4. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.